Ancillary Cannabis Stocks Drop 10% in September

Following up on our discussion earlier this year about how cannabis investors have embraced publicly traded ancillary companies, New Cannabis Ventures launched its seventh proprietary index, the Ancillary Cannabis Index, at the...
- October 1st, 2021 at 8:14 am

Trulieve Completes Harvest Health & Recreation Acquisition

Trulieve Completes Acquisition of Harvest Health & Recreation Inc. Creating the Largest and Most Profitable U.S. Cannabis Operator Combined Company Platform Poised for Accelerated Growth Industry Leading Footprint in...
- October 1st, 2021 at 7:07 am

Cresco Labs to Move Away From Third-Party Distribution in California

Cresco Labs Shifts to Owned-Brand Distribution in California to Increase Profitability, Reduces Third Party Distribution CHICAGO, September 30, 2021–(BUSINESS WIRE)– Cresco Labs Inc. (CSE:CL) (OTCQX:CRLBF) (“Cresco Labs” or “the...
- September 30th, 2021 at 6:30 pm

Trulieve to Borrow $350 Million at 8% for 5 Years

Trulieve Announces $350 Million Private Placement of 8% Senior Secured Notes Leverages Industry Leading Balance Sheet to Provide for Retirement of Certain Harvest Health & Recreation Debt Upon Completion...
- September 30th, 2021 at 5:08 pm

American Cannabis Operator Index Declines 2.7% in September

The American Cannabis Operator Index fell for the seventh straight month after having scored five straight monthly gains, declining 2.7% to 54.47: During Q3, the index lost 22.8%. After gaining 45.7%...
- September 30th, 2021 at 4:33 pm

Aurora Cannabis Q4 Revenue Declines 20% to $54.8 Million

Aurora Cannabis Announces Fiscal 2021 Fourth Quarter Results #1 Canadian LP in Global Medical Cannabis; Total Medical Cannabis Net Revenue Rose 9% Compared to Prior Year; Strong Adjusted Gross...
- September 27th, 2021 at 4:47 pm

This Cannabis ETF Is Bouncing

You’re reading a copy of this week’s edition of the New Cannabis Ventures weekly newsletter, which we have been publishing since October 2015. The newsletter includes unique insight to...
- September 26th, 2021 at 10:55 am

MedMen Q4 Revenue Increases 55% to $42 Million

MedMen Reports 55% Year-Over-Year Quarterly Revenue Growth and Second Consecutive Quarter of Growth in Both Revenue and Retail Adjusted EBITDA Company Continues to Execute Against MedMen 2.0 Growth Plan,...
- September 23rd, 2021 at 4:27 pm